# EMGALITY
> **BLA761063** · Biologics License Application · Sponsor: ELI LILLY AND CO · Approved 2018-09-27
## Drug
- **FDA Application Number:** BLA761063
- **Application type:** Biologics License Application
- **Brand name:** EMGALITY
- **Generic name:** GALCANEZUMAB-GNLM
- **Active ingredients:** GALCANEZUMAB-GNLM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ELI LILLY AND CO
- **Manufacturer:** Eli Lilly and Company
- **First approval:** 2018-09-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761063)
---
*AI Analytics · CC0 1.0*